Clinical Trial Update: Effects of an Anti-Inflammatory Drug in Alzheimer's Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating an anti-inflammatory drug for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED